Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases
Description
Pathological conditions involving the HEART including its structural and functional abnormalities. MeSH
Hierarchy View
Subtype Terms (28)
Arrhythmias, Cardiac
106 drugs (78 approved, 28 experimental)
Carcinoid Heart Disease
2 approved drugs
Cardiac Conduction System Disease
Cardiac Output, Low
18 drugs (11 approved, 7 experimental)
Cardiomegaly
5 drugs (4 approved, 1 experimental)
Cardiomyopathies
110 drugs (62 approved, 48 experimental)
Cardiotoxicity
62 drugs (54 approved, 8 experimental)
Endocarditis
32 drugs (30 approved, 2 experimental)
Heart Arrest
64 drugs (56 approved, 8 experimental)
Heart Defects, Congenital
86 drugs (67 approved, 19 experimental)
Heart Failure
444 drugs (230 approved, 214 experimental)
Heart Valve Diseases
62 drugs (46 approved, 16 experimental)
Myocardial Ischemia
181 drugs (121 approved, 60 experimental)
Myocardial Stunning
11 drugs (9 approved, 2 experimental)
Pericardial Effusion
2 approved drugs
Pericarditis
6 drugs (5 approved, 1 experimental)
Post-Cardiac Arrest Syndrome
10 approved drugs
Postpericardiotomy Syndrome
1 approved drug
Pulmonary Heart Disease
1 approved drug
Rheumatic Heart Disease
8 drugs (6 approved, 2 experimental)
Ventricular Dysfunction
10 drugs (8 approved, 2 experimental)
Ventricular Outflow Obstruction
5 approved drugs
Phase 4 Indicated Drugs (88)
Other Experimental Indicated Drugs (67)
Organization Involved with Phase 4 Indications (168)
Ada and Hagbart Waages Humanitarian and Charity Foundation
Alf and Aagot Helgesens Research Foundation
Canadian Anesthesiologists' Society
CardioVascular Research Foundation, Korea
Centro de estudios en Cardiologia Intervencionista
China Academy of Chinese Medical Sciences
Chinese Academy of Medical Sciences
Daewoong Pharmaceutical Co. LTD.
D'Annunzio University of Chieti–Pescara
Federal University of Rio Grande do Sul
Fundación de Investigación en Red en Enfermedades Cardiovasculares
Guangdong Provincial Hospital of Traditional Chinese Medicine
Harapan Kita Hospital, Jakarta, Indonesia
Heart and Stroke Foundation of Canada
Hellenic Institute for the Study of Sepsis
Hospital Alessandro Manzoni Lecco
Hospital General Universitario Gregorio Marañon
Huazhong University of Science and Technology
Imam Abdulrahman Bin Faisal University
I.M. Sechenov First Moscow State Medical University
Instituto Mexicano del Seguro Social
King Fahad Armed Forces Hospital
Kyoto Prefectural University of Medicine
Lepu Medical Technology (Beijing) Co., Ltd.
Liaoning Hospital of Traditional Chinese Medicine
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of General Medical Sciences (NIGMS)
National Natural Science Foundation of China
People's Liberation Army of China
Samjin Pharmaceutical Co., Ltd.
Shanghai Xuhui District Central Hospital
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Steno Diabetes Center Copenhagen
Technical University of Munich
The Norwegian Council on Cardiovascular Disease
The University of Texas, Dallas
University of British Columbia
University of California, Los Angeles
University of California, San Francisco
University of Campania Luigi Vanvitelli
University of North Carolina at Chapel Hill
University of Roma La Sapienza
University of Southern Denmark
University of Texas, Arlington
University of Texas at Houston
University of Texas, San Antonio
Virginia Commonwealth University
Vita-Salute University of Milano. Italy
WanBangDe Pharmaceutical Group Co.,Ltd.
Organization Involved with Phase 3 Indications (199)
Andalusian Initiative for Advanced Therapies
Andalusian Initiative in Advanced Therapies
Boston Health and Hospitals Department
Canadian Institutes of Health Research (CIHR)
Cardiothoracic Surgical Group of Chinese Society of Pediatric Surgery
Case Western Reserve University
Centers for Disease Control and Prevention (CDC)
Centro Cardiológico del Caribe, Columbia
Children's National Medical Center
Clinical Evaluation Research Unit at Kingston General Hospital
Clinical Trials & Surveys Corp
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Dr. Negrin University Hospital
Fundación Canaria de Investigación Sanitaria
Fundacion Clinica Shaio, Bogota, Colombia
German Atrial Fibrillation Network
Greater Baltimore Medical Center
Hamilton Health Sciences Corporation
Icahn School of Medicine at Mount Sinai
Instituto Dante Pazzanese de Cardiologia
King Faisal Specialist Hospital
Los Angeles Biomedical Research Institute
Maryland Medical Research Institute
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
National Heart Institute, Bach Mai Hospital, Vietnam
National Institute for Medical Research and Development (NIMAD)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Aging (NIA)
National Institutes of Health (NIH)
New England Research Institutes
Novosibirsk Research Institute of Circulation Pathology
Office of Dietary Supplements (ODS)
Oklahoma Medical Research Foundation
Oregon Health and Science University
Pacific Health Research Institute
Palo Alto Medical Research Foundation
Papworth Hospital NHS Foundation Trust
Rajaie Cardiovascular Medical and Research Center
Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)
Salt Lake Clinic Research Foundation
Servicio de Evaluación. Servicio Canario de Salud. Spain
SMT KASHIBAI NAVALE MEDICAL COLLEGE
Spanish Clinical Research Network
Statistics and Epidemiology Research Corporation
St. Joseph Hospital Health Center
The Christie NHS Foundation Trust
University of Alabama, Birmingham
University of California, Berkeley
University of California, Davis
University of California, San Diego
University of Colorado, Denver
University of Erlangen-Nuremberg
University of Las Palmas de Gran Canaria
University of Medicine and Dentistry of New Jersey
University of Southern California
University of Western Brittany
Venezuelan Foundation of Heart Failure
Zhejiang Hisun Pharmaceutical Co. Ltd.
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 2 Indications (73)
California Breast Cancer Research Program
Cardiovascular Cell Therapy Research Network
Centre for Digestive Diseases, Australia
Changchun University of Chinese Medicine
Cohen Children's Medical Center of New York
Cook Children's Medical Center
National Institute of Mental Health (NIMH)
Richardson Centre for Functional Foods and Nutraceuticals
SOLTI Breast Cancer Research Group
St. Antonius Hospital, Nieuwegein
St. Luke's-Roosevelt Hospital Center
The Physicians' Services Incorporated Foundation
Thrombolysis in Myocardial Infarction Study Group
Translational Research Informatics Center, Kobe, Hyogo, Japan
Organization Involved with Phase 1 Indications (16)
Organization Involved with Other Experimental Indications (54)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Alta Bates Summit Medical Center
Beijing Municipal Health Bureau
Dr. Sami Ulus Children's Hospital
Henan Institute of Cardiovascular Epidemiology
Katholieke Universiteit Leuven
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
